[go: up one dir, main page]

ZA977565B - Method for inhibiting the expression of fas - Google Patents

Method for inhibiting the expression of fas

Info

Publication number
ZA977565B
ZA977565B ZA977565A ZA977565A ZA977565B ZA 977565 B ZA977565 B ZA 977565B ZA 977565 A ZA977565 A ZA 977565A ZA 977565 A ZA977565 A ZA 977565A ZA 977565 B ZA977565 B ZA 977565B
Authority
ZA
South Africa
Prior art keywords
fas
inhibiting
expression
Prior art date
Application number
ZA977565A
Other languages
English (en)
Inventor
Giora Zeev Feuerstein
Tian-Li Yue
Original Assignee
Boehringer Mannheim Pharm Corp
Smithkline Beecham Corp Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Pharm Corp, Smithkline Beecham Corp Ltd filed Critical Boehringer Mannheim Pharm Corp
Publication of ZA977565B publication Critical patent/ZA977565B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Fats And Perfumes (AREA)
  • Separation By Low-Temperature Treatments (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA977565A 1996-08-23 1997-08-22 Method for inhibiting the expression of fas ZA977565B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2448696P 1996-08-23 1996-08-23

Publications (1)

Publication Number Publication Date
ZA977565B true ZA977565B (en) 1999-02-17

Family

ID=21820837

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA977565A ZA977565B (en) 1996-08-23 1997-08-22 Method for inhibiting the expression of fas

Country Status (17)

Country Link
US (1) US6096777A (xx)
EP (1) EP0924985A4 (xx)
JP (1) JP2001504804A (xx)
KR (1) KR20000068322A (xx)
CN (1) CN1233150A (xx)
AU (1) AU4083097A (xx)
BR (1) BR9711228A (xx)
CA (1) CA2264178A1 (xx)
CZ (1) CZ59199A3 (xx)
HU (1) HUP9904243A3 (xx)
IL (1) IL128613A (xx)
NO (1) NO990792L (xx)
NZ (1) NZ334307A (xx)
PL (1) PL331766A1 (xx)
TR (1) TR199900370T2 (xx)
WO (1) WO1998007321A1 (xx)
ZA (1) ZA977565B (xx)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2183870C2 (ru) * 2001-06-26 2002-06-20 Байков Юрий Александрович Устройство для защиты от излучения радиотелефонной трубки
US8101209B2 (en) 2001-10-09 2012-01-24 Flamel Technologies Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
US20050148779A1 (en) * 2002-04-30 2005-07-07 Wei Chen Carvedilol monocitrate monohydrate
AU2003251627A1 (en) * 2002-06-27 2004-01-19 Sb Pharmco Puerto Rico Inc. Carvedilol hydrobromide
EP1534270A4 (en) * 2002-06-27 2006-05-17 Sb Pharmco Inc CARVEDILOL PHOSPHATE SALTS AND / OR ITS SOLVENTS, CORRESPONDING COMPOSITIONS AND / OR TREATMENT PROCEDURES
US6632832B1 (en) 2002-09-10 2003-10-14 Dabur Research Foundation Anti-cancer activity of carvedilol and its isomers
WO2004024145A1 (en) * 2002-09-10 2004-03-25 Dabur Research Foundation Anti-cancer activity of carvedilol and its isomers
WO2005051383A1 (en) * 2003-11-25 2005-06-09 Sb Pharmco Puerto Rico Inc. Carvedilol salts, corresponding compositions, methods of delivery and/or treatment
JP2007512350A (ja) * 2003-11-25 2007-05-17 エスビー・ファルムコ・プエルト・リコ・インコーポレイテッド カルベジロール組成物の治療および送達方法
JP5072364B2 (ja) * 2003-11-25 2012-11-14 スミスクライン ビーチャム （コーク） リミテッド カルベジロール遊離塩基、カルベジロール塩、無水形態またはその溶媒和物、対応する医薬組成物、制御放出処方および治療またはデリバリー方法
NZ567266A (en) 2005-10-13 2010-09-30 Orchid Res Lab Ltd Carbazole derivatives as pSTAT3/IL-6 inhibitors (carvedilol)
JP2012051804A (ja) * 2008-12-26 2012-03-15 Kyoto Univ Ｅｇ５阻害剤

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2815926A1 (de) * 1978-04-13 1979-10-18 Boehringer Mannheim Gmbh Neue carbazolyl-(4)-oxy-propanolamin-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
US5393772A (en) * 1993-11-24 1995-02-28 Boehringer Mannheim Pharmaceuticals Corporation Use of, and method of treatment using, hydroxycarbazole compounds for inhibition of smooth muscle migration and proliferation

Also Published As

Publication number Publication date
EP0924985A1 (en) 1999-06-30
HUP9904243A3 (en) 2001-09-28
BR9711228A (pt) 2000-01-11
HUP9904243A2 (hu) 2000-05-28
IL128613A (en) 2004-07-25
AU4083097A (en) 1998-03-06
NO990792L (no) 1999-04-15
NO990792D0 (no) 1999-02-19
CZ59199A3 (cs) 1999-08-11
WO1998007321A1 (en) 1998-02-26
KR20000068322A (ko) 2000-11-25
EP0924985A4 (en) 2000-12-06
IL128613A0 (en) 2000-01-31
PL331766A1 (en) 1999-08-02
US6096777A (en) 2000-08-01
TR199900370T2 (xx) 1999-05-21
CA2264178A1 (en) 1998-02-26
NZ334307A (en) 2000-11-24
JP2001504804A (ja) 2001-04-10
CN1233150A (zh) 1999-10-27

Similar Documents

Publication Publication Date Title
HUP0004592A3 (en) Compounds and methods for the inhibition of the expression of vcam-1
ZA98643B (en) Method for inhibiting the growth of cancers
ZA971709B (en) Method of increasing testosterone
IL129759A0 (en) Process for the preparation of benzyl-ethers
HUP0101896A3 (en) Method and system for the application of lacquer
PL318452A1 (en) Method of obtaining peroxyperfluoropolyoxyalkylenes
HUP0003114A3 (en) Method for the preparation of carbamates
HUP9904243A3 (en) Method for inhibiting the expression of fas
PL330400A1 (en) Method of obtaining azacyclohexapeptides
IL119612A0 (en) Method for the production of khalas
ZA981885B (en) Method for the preparation of alpha-bromo-lactam derivatives
PL332077A1 (en) Method of obtaining omepraole
EP0669361A3 (en) Process for the preparation of polyheterosiloxanes.
IL128026A0 (en) Process for the preparation of hexanitrohexa-azaisowurtzitanes
HUP9901029A3 (en) Method for the production of rdspa alfa1
PL313419A1 (en) Method of obtaining beta-naphtole
ZA984534B (en) Method for the preparation of carbamates
PL333977A1 (en) Method of obtaining benzisothiazolyn-3-ones
GR3035436T3 (en) Process for the preparation of 2-H-heptafluoropropane
GB2330888B (en) Method for the synchronisation of at least two signals
EP0831156A4 (en) 3-ALCOXYMETHYLCEPHEMS PREPARATION PROCESS
PL332075A1 (en) Method of obtaining nizathidine
PL317788A1 (en) Method of obtaining 3-isocyanate-propylsilane
IL116759A0 (en) Process for the preparation of para-fluorophenol
PL301929A1 (en) Method of obtaining epichlorohydine